Literature DB >> 34511814

Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors.

Narendra S Choudhary1, Neeraj Saraf1, Sanjiv Saigal1, Ajay Duseja2, Dheeraj Gautam3, Amit Rastogi1, Prashant Bhangui1, Srinivasan Thiagrajan1, Arvinder S Soin1.   

Abstract

BACKGROUND: Generally diagnosis of non-alcoholic fatty disease is made on imaging, however, mild steatosis is difficult to diagnose on imaging. Liver biopsy is the procedure of choice but is not carried out as it is an invasive procedure. We describe our experience of 157 liver biopsies in living liver donors with normal body mass index (BMI) <23 kg/M2 (lean).
MATERIALS AND METHODS: The study was conducted at a tertiary care center in north India. Data of lean living donors who underwent a liver biopsy before donation were analyzed. Data are presented as percentage, mean, or median (25-75 interquartile range).
RESULTS: Of 718 donors who had a liver biopsy before donation, 157 (21.8%) donors were lean (BMI < 23 kg/M2). Seventy-eight percent of lean donors had no or only one metabolic risk factor. Fifty-three (33.7%) of lean donors had nonalcoholic fatty liver (NAFL) in liver biopsy. When donors with NAFL were compared to donors with normal histology, donors with NAFL had significantly higher aspartate transaminase (26.6 ± 7.5 versus 23.7 ± 5.4, p = 0.007), alanine transaminase (33.4 ± 11.7 versus 27.8 ± 10.7, p = 0.003), and gamma glutamyl transpeptidase [25 (16-40.5) versus 18 (14-23), p = 0.003]. Only triglycerides (TGs) were statistically different among metabolic factors in lean NAFL and normal histology groups, 97 (70-161) versus 86 (62.5-114.7), p = 0.043. A total of 30% donors in the lean NAFL group had TGs >150 mg/dl as compared with 12.5% in the normal histology group, p = 0.009. Other metabolic risk factors were not statistically different.
CONCLUSION: One third of lean donors had NAFL. Among all metabolic risk factors, only higher TGs levels showed a significant association with NAFL.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; CT, computed tomography; GGT, gamma glutamyl transpeptidase; GRWR, graft-to-recipient weight ratio; HDL, high-density lipoprotein; IR, insulin resistance; LAI, liver attenuation index; MR, magnetic resonance; NAFL, nonalcoholic fatty liver; NAFLD, nonalcoholic fatty liver disease; PNPLA3, patatin-like phospholipase domain-containing protein 3; TG, triglyceride; USG, ultrasound; biopsy; metabolic syndrome; triglycerides

Year:  2021        PMID: 34511814      PMCID: PMC8414316          DOI: 10.1016/j.jceh.2021.01.004

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  28 in total

Review 1.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

Authors:  Siddharth Singh; Alina M Allen; Zhen Wang; Larry J Prokop; Mohammad H Murad; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-24       Impact factor: 11.382

2.  Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations.

Authors:  Seung Soo Lee; Seong Ho Park; Hye Jin Kim; So Yeon Kim; Min-Yeong Kim; Dae Yoon Kim; Dong Jin Suh; Kang Mo Kim; Mi Hyun Bae; Joo Yeon Lee; Sung-Gyu Lee; Eun Sil Yu
Journal:  J Hepatol       Date:  2010-02-02       Impact factor: 25.083

3.  Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study.

Authors:  Chengfu Xu; Chaohui Yu; Han Ma; Lei Xu; Min Miao; Youming Li
Journal:  Am J Gastroenterol       Date:  2013-04-09       Impact factor: 10.864

4.  Safe Use of Right Lobe Live Donor Livers With up to 20% Macrovesicular Steatosis Without Compromising Donor Safety and Recipient Outcome.

Authors:  Prashant Bhangui; Jayant Sah; Narendra Choudhary; Dheeraj Gautam; Vikas Gupta; Thiagrajan Srinivasan; Amit Rastogi; Tarun Piplani; Neeraj Saraf; Sanjiv Saigal; Avi Soin
Journal:  Transplantation       Date:  2020-02       Impact factor: 4.939

5.  Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.

Authors:  Dong Hyun Sinn; Geum-Youn Gwak; Ha Na Park; Jee Eun Kim; Yang Won Min; Kwang Min Kim; Yu Jin Kim; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Am J Gastroenterol       Date:  2011-11-22       Impact factor: 10.864

Review 6.  Radiologic evaluation of nonalcoholic fatty liver disease.

Authors:  Seung Soo Lee; Seong Ho Park
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

7.  Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey.

Authors:  Shivaram Prasad Singh; Sachidananda Nayak; Manorama Swain; Niranjan Rout; R N Mallik; Omprakash Agrawal; Chudamani Meher; Mvk Rao
Journal:  Trop Gastroenterol       Date:  2004 Apr-Jun

Review 8.  Nonalcoholic fatty liver disease as a multi-systemic disease.

Authors:  Hakan Fotbolcu; Elçin Zorlu
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

9.  Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects.

Authors:  Mithun Sharma; Anand Kulkarni; Pramod Kumar; Vijay Bhaskar Nori; Nitin Jagtap; Rajesh Gupta; Duvurr Nageshwar Reddy; Padaki Nagaraja Rao
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

10.  Insulin resistance and body fat distribution in South Asian men compared to Caucasian men.

Authors:  Manisha Chandalia; Ping Lin; Thanalakshmi Seenivasan; Edward H Livingston; Peter G Snell; Scott M Grundy; Nicola Abate
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

View more
  4 in total

1.  Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population.

Authors:  Mohammad S Kuchay; Narendra S Choudhary; Deepak Sharma; Sonal Krishan; Sunil K Mishra; Jasjeet S Wasir; Manish K Singh; Neeraj Saraf; Swapnil Dhampalwar; Randhir Sud
Journal:  J Clin Exp Hepatol       Date:  2021-10-13

2.  Revealing the Mechanism of Huazhi Rougan Granule in the Treatment of Nonalcoholic Fatty Liver Through Intestinal Flora Based on 16S rRNA, Metagenomic Sequencing and Network Pharmacology.

Authors:  Yingying Liu; Yingying Tan; Jiaqi Huang; Chao Wu; Xiaotian Fan; Antony Stalin; Shan Lu; Haojia Wang; Jingyuan Zhang; Fanqin Zhang; Zhishan Wu; Bing Li; Zhihong Huang; Meilin Chen; Guoliang Cheng; Yanfang Mou; Jiarui Wu
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

3.  Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns.

Authors:  Liu Lei; Wang Changfa; Wang Jiangang; Chen Zhiheng; Yuan Ting; Zhu Xiaoling; Deng Yuling; Wang Yaqin
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

Review 4.  NAFLD in normal weight individuals.

Authors:  Johanna K DiStefano; Glenn S Gerhard
Journal:  Diabetol Metab Syndr       Date:  2022-03-24       Impact factor: 5.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.